HKD 36.2
(-0.82%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.66 CNY | 54.79% |
2022 | -1.46 CNY | 32.41% |
2021 | -2.16 CNY | -191.89% |
2020 | -0.74 CNY | 50.99% |
2019 | -1.51 CNY | 91.24% |
2018 | -17.24 CNY | -3348.0% |
2017 | -0.50 CNY | -11.11% |
2016 | -0.45 CNY | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.12 CNY | 57.14% |
2024 Q2 | -0.12 CNY | 0.0% |
2023 Q3 | -0.28 CNY | -518.1% |
2023 Q1 | -0.05 CNY | 88.95% |
2023 Q2 | -0.05 CNY | 0.0% |
2023 Q4 | -0.28 CNY | 0.0% |
2023 FY | - CNY | 54.79% |
2022 Q2 | -0.32 CNY | 0.0% |
2022 Q4 | -0.41 CNY | 0.0% |
2022 FY | - CNY | 32.41% |
2022 Q3 | -0.41 CNY | -28.12% |
2022 Q1 | -0.32 CNY | 45.76% |
2021 Q4 | -0.59 CNY | 0.0% |
2021 Q3 | -0.59 CNY | -68.57% |
2021 Q2 | -0.35 CNY | 0.0% |
2021 Q1 | -0.35 CNY | -150.0% |
2021 FY | - CNY | -191.89% |
2020 FY | - CNY | 50.99% |
2020 Q4 | -0.14 CNY | 0.0% |
2020 Q3 | -0.14 CNY | 39.13% |
2020 Q2 | -0.23 CNY | 0.0% |
2020 Q1 | -0.23 CNY | 45.24% |
2019 FY | - CNY | 91.24% |
2019 Q1 | -0.31 CNY | 94.41% |
2019 Q3 | -0.42 CNY | -35.48% |
2019 Q4 | -0.42 CNY | 0.0% |
2019 Q2 | -0.31 CNY | 0.0% |
2018 Q1 | 0.59 CNY | 133.71% |
2018 Q4 | -5.55 CNY | 0.0% |
2018 Q3 | -5.55 CNY | -1040.68% |
2018 Q2 | 0.59 CNY | 0.0% |
2018 FY | - CNY | -3348.0% |
2017 Q1 | -1.19 CNY | 0.0% |
2017 FY | - CNY | -11.11% |
2017 Q4 | -1.75 CNY | 0.0% |
2017 Q3 | -1.75 CNY | -47.06% |
2017 Q2 | -1.19 CNY | 0.0% |
2016 FY | - CNY | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Uni-Bio Science Group Limited | 0.01 HKD | 6045.946% |
CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | 36766.667% |